CVS’s drug-benefits unit, known as Caremark, earlier this month negotiated a deal to make Novo’s Wegovy more widely available to its customers — knocking Eli Lilly & Co. ’s Zepbound off its list of ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand in the U.S. Karsten Munk Knudsen, Novo Nordisk’s chief financial ...

Caremark negotiated an undisclosed lower net price for Wegovy over Zepbound on its standard formularies, offering savings on Novo Nordisk's drug to clients that opt into those plans. But ...

Q1 Wegovy sales rose 85% to DKK 17.36 billion; Ozempic up 18% to DKK 32.72 billion. Novo Nordisk's Q1 sales hit $10.89 billion, missing the $11.64 billion consensus estimate. Don’t miss this ...

The research reportedly involves developing a patch, no larger than a thumbnail, designed to deliver medication through the skin using micro-needles. These needles are ... the key ingredient in ...

He told The Australian Financial Review he intended to follow up his words with changes. Wegovy injection pens. The weight-loss product has helped Eucalyptus earn about $200 million in the past 18 ...

the maker of the weight-loss drug Wegovy. San Francisco-based Hims & Hers said the plan was to make obesity care “more accessible, more affordable and more connected” for Americans.

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Starting July 1 ...

In a press release, the Danish drugmaker said that from July 1, CVS Caremark, the largest pharmacy benefit manager in the U.S., has agreed to make Wegovy, the preferred GLP-1 medicine, on its ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...